Switching to Versus Addition of Incretin-Based Drugs Among Patients With Type 2 Diabetes Taking Sodium-Glucose Cotransporter-2 Inhibitors

Apr-22

AUTHORS : Dr Carlos K. H. Wong, PhD, Department of Pharmacology and Pharmacy/Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Rm 1‐01, 1/F, Jockey Club Building for Interdisciplinary Research, 5 Sassoon Rd, Pokfulam, Hong Kong, Hong Kong SAR, China – Email: carlosho@hku.hk – Profile: https://www.pharma.hku.hk/en/Our-People/Professoriate/Assistant-Professor/Dr-Carlos-KH-WONG/Dr-Carlos-KH-WONG-Profile

JOURNAL : Journal of the American Heart Association

REFERENCE: 11(7):e023489

DOI : 10.1161/JAHA.121.023489

Switching to Versus Addition of Incretin-Based Drugs Among Patients With Type 2 Diabetes Taking Sodium-Glucose Cotransporter-2 Inhibitors

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease